9th Circ. Won't Rethink Upending Sutter Health Antitrust Win

By Bryan Koenig · August 12, 2024, 9:33 PM EDT

The Ninth Circuit refused Monday to reconsider a panel's split decision overturning Sutter Health's defeat of insurance plan purchasers' $400 million antitrust suit, summarily rejecting hospital system arguments that the court...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Djeneba Sidibe, et al v. Sutter Health

Case Number

Court

Appellate - 9th Circuit

Nature of Suit

3410 Antitrust

Date Filed

April 28, 2022

Recent Articles By Bryan

October 21, 2024
PBMs Keep Door Open To Constitutional Riposte Against FTC
October 16, 2024
Caremark, Optum Say FTC Insulin Case Gets PBMs All Wrong
October 15, 2024
'Extraordinary' Blue Cross Deal Includes $2.8B Payout
October 07, 2024
Merck Immune For 'Inflated' Vax Claims To FDA, 3rd Circ. Says
September 06, 2024
Actelion Must Face Tracleer Antitrust Suit With Class Certified
August 28, 2024
Jazz, Hikma Must Face Bulk Of Xyrem Antitrust Suit
August 14, 2024
Nursing Co. Exec Can't Split Up Fraud, Wage-Fixing Charges
July 31, 2024
Inhaler Patents 'Must Be' In Orange Book, Teva Tells Fed. Circ.
July 17, 2024
Heart Doctor's Sham Suit Claims Cut From Antitrust Row
July 11, 2024
Fed. Circ. Pauses Ouster Of Teva Patents From Orange Book